Literature DB >> 1583352

Molecular form of pancreatic elastase 1 in human plasma.

S Hayakawa1, T Hayakawa, T Kondo, T Shibata, S Naruse.   

Abstract

In order to study the molecular forms of immunoreactive pancreatic elastase 1 (IRE) in human plasma, we investigated the characteristics of proelastase 1, elastase 1, and their alpha 1-protease inhibitor (alpha 1-PI) complexes on anion-exchange (Mono Q) chromatography, gel (Superose 12) chromatography, and enzyme immunoassay systems with monoclonal antielastase 1 antibodies of different affinities for alpha 1-PI-elastase 1 and alpha 1-PI-proelastase 1 complexes. The rate of complex formation between proelastase 1 and alpha 1-PI was dependent on temperature of incubation and concentration of alpha 1-PI. At 37 degrees C, 90% of proelastase 1 was bound to alpha 1-PI during 2 h of incubation of purified human proelastase 1 with human alpha 1-PI. Similar results were also obtained by 2 h of incubation of proelastase 1 with human plasma at 37 degrees C. Therefore, under physiological conditions, neither free proelastase 1 nor elastase 1 can be detected in the human blood stream, and most IRE exists as the complex of proelastase 1 with alpha 1-PI in human plasma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583352     DOI: 10.1007/bf02925986

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  20 in total

1.  Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma.

Authors:  A Borgström; K Ohlsson
Journal:  Scand J Clin Lab Invest       Date:  1976-12       Impact factor: 1.713

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Enzyme immunoassay of the glycoprotein tropic hormones--choriogonadotropin, lutropin, thyrotropin--with solid-phase monoclonal antibody for the alpha-subunit and enzyme-coupled monoclonal antibody specific for the beta-subunit.

Authors:  H G Wada; R J Danisch; S R Baxter; M M Federici; R C Fraser; L J Brownmiller; J C Lankford
Journal:  Clin Chem       Date:  1982-09       Impact factor: 8.327

4.  Interaction of chymotrypsinogens with alpha 1-protease inhibitor.

Authors:  J W Brodrick; C B Glaser; C Largman; M C Geokas; M Graceffo; M Fassett; H Maeda
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

5.  Human pancreatic proteolytic enzymes and protein inhibitors. Isolation and molecular properties.

Authors:  G Feinstein; R Hofstein; J Koifmann; M Sokolovsky
Journal:  Eur J Biochem       Date:  1974-04-16

6.  [Molecular forms of human pancreatic elastase 1 in serum and determination by radioimmunoassay. (author's transl)].

Authors:  A Murata; K Fujimoto; T Kitahara; Y Matsuda; M Ogawa; G Kosaki
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1981-10

7.  Purification and characterization of two human pancreatic elastases.

Authors:  C Largman; J W Brodrick; M C Geokas
Journal:  Biochemistry       Date:  1976-06-01       Impact factor: 3.162

8.  Serum elastase I levels in pancreatic disease.

Authors:  K Satake; Y S Chung; K Umeyama
Journal:  Am J Surg       Date:  1982-08       Impact factor: 2.565

9.  Radioimmunoassay of human pancreatic elastase 1. In vitro interaction of human pancreatic elastase 1 with serum protease inhibitors.

Authors:  A Murata; M Ogawa; K Fujimoto; T Kitahara; Y Matsuda; G Kosaki
Journal:  Enzyme       Date:  1983

10.  Demonstration of a pancreatic proelastase 2-alpha 1-protease inhibitor complex in normal human plasma.

Authors:  C Largman; J W Brodrick; M C Geokas; J H Johnson; M Fassett
Journal:  Am J Physiol       Date:  1980-03
View more
  2 in total

1.  What is human pancreatic proelastase 1?

Authors:  C Figarella
Journal:  Int J Pancreatol       Date:  1992-06

2.  Trypsin(ogen) content of pancreatic calculi in chronic calcified pancreatitis in man.

Authors:  T Hayakawa; T Kondo; T Shibata; M Kitagawa; Y Nakae; S Hayakawa
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.